Home » Topics » Regulatory » Patents

Patents
RSS

GlaxoSmithKline presents novel TRPV4 channel antagonists

Oct. 27, 2011

New glucagon receptor antagonists designed by Merck & Co.

Oct. 26, 2011

Italian researchers prepare novel TRPV1 antagonists

Oct. 26, 2011

Merck Frosst discloses new HIV reverse transcriptase inhibitors

Oct. 26, 2011

Novel TRPV4 antagonists prepared by researchers at GlaxoSmithKline

Oct. 26, 2011

Scientists at Astellas Pharma synthesize novel plasma kallikrein inhibitors

Oct. 26, 2011

Novel spider venom-derived contraceptive peptides designed in Chile

Oct. 25, 2011

Ajinomoto presents new factor Xa inhibitors

Oct. 25, 2011

Novel B-raf inhibitors disclosed by Boehringer Ingelheim

Oct. 25, 2011

New phosphodiesterase 10A inhibitors prepared by Roche

Oct. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...